Our business extends far beyond our supply chain capabilities across the globe. Our infrastructure allows us to provide rapid and accurate order fulfillment. These segments offer different products and services to the same customer base. Our competitive strengths include: A focus on meeting our customers' unique needs. Broad product and service offerings at competitive prices. We also provide consulting services, dental practice valuation and brokerage services. 8226; Comprehensive ordering process. We distribute our products from our strategically located distribution centers. Between 2020 and 2040, this age group is expected to grow by approximately 22%. We are also subject to foreign government regulation of such products. In the meantime, rules provided for by Directive No. EU law also regulates competition and provides for detailed rules protecting consumers. The Fifth Circuit's decision was appealed to the United States Supreme Court. We refer to our employees as Team Schein Members, or "TSMs." As a result, D&I helps us meet the needs of customers around the world. Brad Connett has been our President of the U.S. Medical Group since 2018. Prices for certain PPE have been volatile. We generally sell products to customers with payment terms. 726/2004 or, as regards data protection, the GDPR. Data Subjects also have the right to seek compensation for damages. 3) During the fourth quarter of 2019, we sold an equity investment in Hu-Friedy Mfg. Co., LLC, a manufacturer of dental instruments and infection prevention solutions. During the fourth quarter of 2019, we also sold certain other equity investments. However, the extent of the potential impact cannot be reasonably estimated at this time. These activities were originally expected to be completed by the end of 2020. On February 7, 2019, we completed the Animal Health Spin-off. As of December 26, 2020, we had no borrowings under this credit facility. At December 26, 2020, the interest rate on this facility was 2.50%. These adjustments do not impact the calculation of earnings per share. This occurs when the equipment is delivered. There are no cases where revenue is deferred due to a lack of a standalone selling price. When an impairment exists, the related assets are written down to fair value. The Plans are administered by the Compensation Committee of the Board of Directors. This swap will offset changes in our SERP and DCP liabilities. At the inception, the notional value of the investments in these plans was $43.4 million. This swap is expected to be renewed on an annual basis. All intercompany accounts and transactions are eliminated in consolidation. Table of Contents HENRY SCHEIN, INC. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021. 8226; Level 3— Inputs that are unobservable for the asset or liability. Please see Note 16 – Derivatives and Hedging Activities for additional information. On June 10, 2013, Archer moved for reconsideration before the District Court judge. We intend to defend ourselves vigorously against this action. 17-md-2804) in an action entitled The County of Summit, Ohio et al. Opioids represent a negligible part of our business. was also filed in the U.S. District Court for the Eastern District of New York, Case No. We believe that our audit provides a reasonable basis for our opinion. 2.5 Letter Agreement and Amendment No. 10.17 Amendment to the Henry Schein, Inc. Deferred Compensation Plan. ( These costs are in